Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Editorial
Journal Review
Journal Summary
Letter to Editor
Letter to the Editor
Original Article
Review Article
Summary
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Editorial
Journal Review
Journal Summary
Letter to Editor
Letter to the Editor
Original Article
Review Article
Summary
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Editorial
Journal Review
Journal Summary
Letter to Editor
Letter to the Editor
Original Article
Review Article
Summary
View/Download PDF

Translate this page into:

Review Article
41 (
2
); 72-82
doi:
10.25259/KPJ_7_2026

Optimising functional recovery after paediatric stroke: Complications, non-pharmacological management and neurorehabilitative strategies: A comprehensive literature review

Department of Medicine, Tbilisi State Medical University, Tbilisi, Georgia,
Department of Medicine, Ivan Horbachevsky Ternopil National Medical University, Ternopil, Ukraine,
Department of Medicine, Hamad Medical Corporation, Doha, Qatar.

*Corresponding author: Rowyna Reji Koshy, Department of Medicine, Tbilisi State Medical University, Tbilisi, Georgia. rowkoshy@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Koshy RR, Bahl D, Muhammed M, Kumar AA, Preman P, Raziya F, et al. Optimising functional recovery after paediatric stroke: Complications, non-pharmacological management and neurorehabilitative strategies: A comprehensive literature review. Karnataka Paediatr J. 2026;41:72-82. doi: 10.25259/KPJ_7_2026

Abstract

Paediatric stroke (PS) is an uncommon but serious medical emergency and a major cause of long-term disability in children around the world. It affects approximately 1 in 25,000 children per year, with the incidence seen more in the neonatal period. PS is different from adult stroke in both aetiology and clinical presentation. Causes can vary from congenital heart disease, cerebral arteriopathies, to vascular malformations. Clinical features vary with age, ranging from seizures and non-specific systemic symptoms in infants to focal neurological deficits in older children, and are associated with delayed diagnosis. MRI, along with vascular imaging techniques, is the preferred diagnostic modality in children due to its superior sensitivity. Neurorehabilitation is fundamental to improving functional recovery and quality of life post-PS. The heightened neuroplasticity of the developing brain highlights the importance of early, intensive, and task-oriented rehabilitation. Emerging non-pharmacological interventions are structured physical exercise, occupational and cognitive therapy, neuromuscular electrical stimulation, robotic-assisted rehabilitation, and virtual reality. This review highlights current advances in PS management with a focus on neurorehabilitation and non-pharmacological management.

Keywords

Neurorehabilitation
Non-pharmacological intervention
Paediatric stroke

INTRODUCTION

One of the leading causes of illness and death for children worldwide is stroke. According to the Global Cost of Disease study from 1990 to 2013, the quantity of paediatric strokes (PSs) increased by 35%. Each year, there are 1.2–2.1 cases of childhood acute ischemic stroke (AIS) and 0.7–5.1 instances of haemorrhagic stroke (HS) per 100,000 children. The mortality ranges for AIS 6–9 and HS 3–5 are 3.6–14% and 6–54%, respectively, with deaths from stroke or underlying infections.[1] PS can be caused by a variety of factors, including neonatal encephalopathies, abnormal cerebral vessel development (usually arteriovenous), inherited or acquired prothrombotic conditions, inherited blood vessel abnormalities, and genetic syndromes.[2]

The child’s stroke location has an impact on how AIS manifests clinically. Seizures or other diffuse neurologic impairments are common in infants who have had strokes. When neurologic signs, like developing hemiparesis or convulsions, early neuroimaging and certain stroke-affected newborns are diagnosed after the fact rather than immediately. On the other hand, focal neurologic impairments, such as focal seizures with or without hemiplegia, are typical in children who have had a stroke. The symptoms of stroke in children are often mixed up with those of other common neurological or systemic conditions. It has been demonstrated that symptoms such as focal weakness, seizures, ataxia, difficulty speaking, or trouble walking might differentiate stroke from migraine, a common stroke mimic in children. Improved screening technologies to support healthcare professionals may help reduce diagnosis delays that affect the research and application of acute therapy for stroke patients.[3] The goal of paediatric neurorehabilitation is to provide children as much independence as possible in their daily lives.[4] To help patients with neurological injuries improve recovery and lessen disability, neurorehabilitation is a complex interdisciplinary collection of pharmaceutical and non-pharmacological interventions.[5] Effective neurorehabilitation follows the sensorimotor and cognitive learning model, which emphasises task-oriented, intensive practice and engagement. All those things need a great deal of dedication, which is often difficult for children to pursue.[6] Although neuromodulation methods such as transcranial magnetic stimulation (TMS), which stands for TMS, and transcranial direct current stimulation (tDCS), which is tDCS, are utilised along with motor training have proven effective in stroke and cerebral palsy, innovative approaches like virtual environments and gaming technologies improve motivation and therapy adherence.[4,7] But due to variations in the anatomy and function of the developing brain impacted by brain damage, they provide extra difficulties.[7] The discussion in this paper outlines the current comprehension of PS, encompassing its epidemiology, complications, innovations in rehabilitation, non-pharmacological methods, and screening techniques.

MATERIAL AND METHODS

The aim of this review was to evaluate the potential upcoming neurorehabilitation features of PS, as well as to create a study for awareness of PS. For this, we employed a narrative literature review approach and searched for relevant literature in databases such as PubMed and Google Scholar using keywords such as ‘Paediatric stroke’, ‘neurorehabilitation’, and ‘Advancements’. The inclusion criteria include old to new articles, helping us understand the history to status of this approach, as well as case reports, original research articles, and reviews were assessed. Information pertinent to this review was included, whereas non-English and unrelated articles were excluded as part of the exclusion criteria.

The review was conducted over a time frame from September 2025 to January 2026 to ensure a structured and comprehensive assessment of both historical and contemporary evidence in this field, following various processes of literature search, writing this study after analysis of various scholarly articles. The inclusion criteria encompassed peer-reviewed articles published in English, ranging from older foundational studies to the most recent publications available during the review period. Original research articles (in vitro, animal, and human studies), clinical trials, observational studies, case reports, and narrative or systematic reviews were considered eligible if they addressed the current updates on understanding PS as well as the neuro-rehabilitative strategies used for this condition. Studies focusing only paediatric population were considered. Exclusion criteria consisted of non-English publications, conference abstracts without full-text availability, editorials, opinion pieces, and studies unrelated to this topic. The initial literature search yielded a total of 60 articles. Following preliminary screening of titles and abstracts, duplicate records and clearly unrelated publications were removed. Full-text assessment was subsequently performed, resulting in the exclusion of additional studies that did not meet the predefined inclusion criteria. Ultimately, 43 articles were selected and included for qualitative synthesis in this review.

Data extraction was performed manually by all the authors, focusing on study design, population characteristics, type of strategies that are not dependent on pharmacological treatment, proposed mechanisms of action, and reported outcomes in children. Given the narrative nature of this review, there was no formal quality assessment or meta-analysis that was conducted. Instead, findings were synthesised descriptively to highlight emerging patterns, mechanistic insights, and gaps in the existing literature.

RESULTS

The reviewed literature highlights PS as a significant cause of long-term neurological morbidity, despite its relatively low incidence. The two main subtypes identified were arterial ischaemic stroke and HS, with HS showing greater fatality rates (6–54%) than arterial ischaemic stroke (3.6–14%). Males were more commonly afflicted than females, and 25% cases were documented of recurrence, particularly in children with underlying arteriopathies. Clinical presentation varied markedly by age, with seizures being the most common presenting feature in infants while focal neurological deficits, especially hemiparesis, predominated in older children. Non-specific symptoms such as headache, vomiting, fever, and altered mental status were common across all age groups, contributing to frequent diagnostic delays. Long-term outcomes revealed high rates of persistent disability with hemiplegia reported in 44–66% of survivors and cognitive or behavioural impairments. Neurorehabilitation interventions showed positive effects on functional recovery. Emerging non-pharmacological strategies like robotic-assisted therapy, neuromuscular electrical stimulation (NMES), virtual reality (VR), structured physical exercise, and psychological support. However, evidence remains limited, emphasising the need for larger paediatric-specific research to advance the critical care given to these patients.

DISCUSSION

PS overview

An acute neurologic emergency, such as a stroke, necessitates prompt diagnosis, central nervous system imaging, and treatment ideally within the designated time limit. In paediatric patients, stroke is linked to considerable morbidity and mortality.[8] It has a significant impact on a child’s development, influencing their social skills, learning, and quality of life.[9] Research has revealed that the prevalence of infantile stroke varies greatly. According to estimates, there are between 2.5 and 13 strokes for every 100,000 children annually.[10] PS is divided into two categories based on when it occurs: perinatal stroke, which happens between the 20th week of pregnancy and 28 days after delivery, and childhood stroke, which happens between 29 days and 18 years of age.[9]

Children experience strokes for a far wider range of reasons than adults do. In adults, the major risks usually come from long-term conditions like atherosclerosis, diabetes, or high blood pressure.[11] In contrast, paediatric AIS can result from many different problems, such as vascular abnormalities, congenital heart disease, blood conditions including sickle cell disease or clotting issues, infections, trauma and even certain genetic or metabolic conditions.[12]

The most common stroke symptom in infants is seizures. Older children were more likely to have focal deficits, primarily hemiparesis. Most importantly, seizures that were experienced by 37% of attendees indicate that they are extremely common in all age categories. In general, non-specific systemic symptoms such as fever, headache, nausea/ vomiting, and cardio-pulmonary failure were prevalent, both with and without focal deficits.[10] In children who are thought to be having a stroke, the first test usually done is a non-contrast computed tomography (CT) scan. It is quick and can reliably show fresh bleeding, but it is not always good at detecting subarachnoid haemorrhage or the very early signs of ischaemia. MRI, along with magnetic resonance angiography (MRA) and magnetic resonance venography (MRV), tends to provide a much clearer view, especially when doctors need to check for venous thrombosis, look for areas of infarction, or assess the blood vessels in detail. CT angiography can also give fast information about the vessels, though it comes with higher radiation exposure. Catheter angiography is still considered the most accurate way to assess the cerebral circulation, but because it is invasive, it is used only when really needed. Other parts of the work-up may include a carotid scan, a heart examination, and laboratory tests to look for underlying metabolic or haematologic issues.[11]

Treatment options such as IV thrombolysis, mechanical thrombectomy, and antiplatelet therapy are mostly borrowed from adult practice, which creates real challenges when managing children. If blood flow cannot be restored early, the injured brain tissue often cannot recover, and this delay usually leads to significant long-term disability.[12] Effective implementation necessitates the involvement of clinicians, hospital administrators, government officials, research funding organisations, and stroke advocacy groups. Priorities include coordinated regional stroke systems with established hospital bypass procedures to accredited primary stroke centres capable of providing reperfusion therapies, multidisciplinary PS teams, and the development of institutional PS Code protocols, which include rapid imaging protocols, validated clinical decision support tools, and parallel work practices to increase efficiencies.[1]

Although people are becoming more aware of the challenges young stroke survivors face, there’s still very little research on what their return to school looks like. The majority of reviews that are currently available concentrate on rehabilitation or general cognitive problems, but they rarely dive into how these children manage academically or how well they cope with day-to-day school demands.[9] Creating dedicated stroke clinics that can offer thrombolysis, thrombectomy, and follow-up treatment is essential to improve outcomes for young stroke patients. However, we still need much more research to ascertain the most efficient and secure dosage and protocols for thrombolytic therapy in paediatric acute stroke. In addition, gaining real-world clinical experience and stronger evidence on the use of endovascular bridging therapy in children is key to advancing treatment options for this population.[12]

PS statistical analytic incidence

Stroke is one of the principal causes of disability and mortality among children.[13] Every year, about 1 in 25,000 children have a childhood stroke, and 75% of them have long-term neurologic morbidity.[14] Stroke was the third-largest cause of mortality at the Global Burden of Disease level 3 in 2021, after only ischaemic heart disease and Covid-19, and ranked fourth in disability-adjusted life years (DALYs). Globally, there were 11.9 million strokes in 2021, which led to 7.3 million fatalities and 160.5 million DALYs.[15]

In the current study, common risk factors for AIS were vasculitis, vasculopathy, hyper coagulopathy, and cardiac disease, while common risk factors for HS were bleeding diathesis, vascular abnormality, and intracranial tumour. There is a trend of difference in stroke risk factors between developed and developing nations, with infectious causes being more prevalent in developing nations. Vasculopathy (35.5%), heart disease (17.4%), metabolic disease (14.5%), infection (14.5%), and coagulopathy (1.6%) were among the risk factors identified in another study. Major cardiovascular risk factors include congenital heart disease, particularly cyanotic heart disease, acquired heart disease, and patent foramen ovale. Prior studies have linked congenital heart disease, mainly cyanotic congenital heart disease (CHD), to as much as 15% of ischaemic strokes.[16]

The most frequent presenting symptoms in stroke patients are facial weakness (33.3%), impaired mental status (50%), and hemiparesis (66.7%). Non-stroke patients, on the other hand, were more likely to present with hemiparesis (57.1%), speech alterations such as dysarthria or aphasia (39.3%), sensory changes such as loss or numbness (32.1%), and facial weakness (35.7%).[14] A 16-year prospective national study called the Canadian Paediatric Ischaemic Stroke Registry produced comprehensive data on the incidence, presentation, risk factors, and therapies of paediatric arterial ischaemic stroke. The incidence of stroke among the 1,129 children who participated in the study was 1.72/100,000/ year for children aged 29 days to 18 years and 10.2/100,000 live births for neonates aged 0–28 days. In addition, boys have a greater prevalence and incidence than girls, and black children have an increased risk compared to Caucasian and Asian children. Stroke mortality in children ranges between 10-25%.[10] In 2013, the global prevalence of ischaemic stroke in the paediatric population was 40,000, a 35% increase from 1990, with death rates of 7–28% after childhood arterial ischaemic stroke.[15] The analysis’s pooled yearly incidence rates of AIS for the entire age group (4.58/100,000 children aged 0–17/18 years) fell within the range in previous studies (0.6–7.9/100,000 children)[17] [Figure 1].

Identified risk factors for PS. PS: Paediatric stroke.
Figure 1:
Identified risk factors for PS. PS: Paediatric stroke.

Arterial ischaemic stroke (AIS) is exceedingly rare in children, occurring in <2–3/100,000. Compared with adults, presentations are frequently inconsistent, which delays identification and treatment. If the delay is longer than 24 h, it can spike mortality and morbidity and can lead to long-term neurologic compromise in up to 85% of patients.[18] The rates for paediatric arterial ischaemic stroke, neonatal stroke, and cerebral sinus venous thrombosis are 1.28, 18.51, and 0.56/100,000 person-years, respectively.[19] In developing nations, the prevalence of HS is about twice as high as in developed countries. On the contrary, the prevalence of ischaemic stroke has historically been 4–5 times higher in developing nations than in developed countries. Based on one study, among the causes of HS, 13% of patients had an underlying cerebral aneurysm, 31% had brain arteriovenous malformations, 2.5% had brain tumours, 25% had an unexplained aetiology, and 28.5% had various medical and structural aetiology origins.[20] The mortality rate of HS is substantially higher than that of arterial ischaemic stroke.[10] Arterial ischaemic stroke (AIS) mortality ranges between 3.6-14%, while HS mortality ranges from 6-54%, with the stroke or underlying illness being the cause of death.[1] Following the first occurrence, up to 25% of children will experience a recurrent stroke[10] [Figure 2].

Aetiology of paediatric haemorrhagic stroke. AVM: Arteriovenous malformation.
Figure 2:
Aetiology of paediatric haemorrhagic stroke. AVM: Arteriovenous malformation.

PS complications

Stroke is in the top 10 causes of death in children and survivors having disabilities, at a substantial cost to themselves and their families.[1] PS causes significant morbidity in children, resulting in lifelong neurological disability.[21] Commonly, it is more detrimental in the paediatric population due to its occurrence at a younger age and therefore could result in a longer duration of disability that can last an entire lifespan.[10]

Although congenital heart disease and transient cerebral arteriopathy are two common causes of PS, post-minor injury basal ganglia stroke has recently been identified as a common aetiology in resource-limited settings.[22] Despite having a better prognosis than adults, more than 20% children experience a moderate to severe degree of neurologic damage, and their incidence of depression is nearly double that of their matched cohorts.[10] Concerningly, some of the patients reported having movement disorders like hemidystonia on the hemiparetic side, a few days after the onset of stroke. Acute illness is significantly more common in young (<5 years) children with stroke, and it strongly predicts abnormal outcomes. Nevertheless, acute illnesses concurrent with the stroke, with their associated fever, hypoxia, hypoglycaemia, azotaemia, and so on, may have increased stroke severity through altered metabolism both within the involved part of the brain and the surrounding penumbra.[23] Children’s HSs can be classified as intracerebral haemorrhage (ICH), intraventricular haemorrhage, or subarachnoid haemorrhage. HS accounts for over half of all PSs, with an annual incidence of around 1–1.7/100,000.[24]

After an arterial ischaemic stroke (AIS), the rate of fatal events spans from 1-32% among various paediatric patient groups.[19] The emergence of an arteriopathy was the best predictor of stroke recurrence, giving rise to a 5-fold increase in risk. This risk was present despite increased use of antithrombotic agents.[24]

PS is a complicated neurological concern that has significant cognitive and functional detriments. Therefore, an effective rehabilitation is critical for supporting the recovery and improving outcomes in affected children[9] [Figure 3].

Description for PS outcomes, complications, and challenges. PS: Paediatric stroke; ICH: intracerebral haemorrhage; IVH: Intraventricular haemorrhage; SAH: Subarachnoid haemorrhage; AIS: Arterial ischaemic stroke.
Figure 3:
Description for PS outcomes, complications, and challenges. PS: Paediatric stroke; ICH: intracerebral haemorrhage; IVH: Intraventricular haemorrhage; SAH: Subarachnoid haemorrhage; AIS: Arterial ischaemic stroke.

Neurorehabilitation for PS

The rarity of PS compared to adult stroke contributes to limited specialised rehabilitation protocols, yet the consequences are profound. Motor impairments post-PS often manifest as hemiparesis or hemiplegia, with very high persistence rates. Long-term motor outcomes after childhood stroke have reported persisting hemiplegia in 44–66% of cases.[25] The term ‘robotic rehabilitation’ describes therapies that help retrain movement using robotic equipment (such as exoskeletons, robotic arms and legs, gait trainers, hand and arm robots). The term ‘robotic rehabilitation’ describes therapies that help retrain movement using robotic equipment (such as exoskeletons, robotic arms and legs, gait trainers, hand and arm robots). These tools enable controlled, repetitive, and frequently intense training that might be challenging to duplicate in conventional therapy.

A frequent outcome of this seen post-stroke is unilateral hand disability and hemiparesis.

A case study was conducted on a 7.5-year-old girl in the chronic phase of post-stroke rehabilitation. Robotic neurorehabilitation was started 18 months after the stroke, and it consisted of 30 min of personalised kinesitherapy and 30 min of VR-based rehabilitation using the robotic smart glove. Among the measurement variables examined were the arm’s functional motor state, gripping, spasticity, and participation in everyday activities. The study found that the combination of kinesitherapy and robotic rehabilitation greatly enhanced the arms’ functional motor performance.[26]

On the gait side, powered wearable robotic exoskeletons, which are electromechanical devices with bilateral motorised support at the knee and hip joints, have been the focus of recent technological developments. They reduce the therapist’s work by offering adjustable high-intensity, high-dose therapy sessions with efficient over-ground ambulation. In comparison to the group that received only physical therapy (PT), the patients treated with the wearable powered robotic exoskeleton regained a more physiological stride, as seen by the proximal lower limb muscle activation patterns. One of the chief goals of a rehabilitation program for stroke patients is the restoration of symmetric and effective walking. When combined with physical treatment, the usage of overground exoskeletons may promote rhythmic muscle activation, which could result in a more effective gait. The same study systematically evaluated therapist workload- It showed that patients and parents embrace robotic neurorehabilitation therapy and that physiotherapists derive some professional fulfilment from it, despite the fact that initially it requires more work.[27] There isn’t a single, widely recognised ‘technique’. Different facilities combine robotics with traditional therapy or VR.[28] Economic and long-term burdens amplify the need for effective interventions.[29] Although promising, case reports must be replicated in a larger youth stroke cohort that includes both ischaemic and haemorrhagic patients to evaluate differences in treatment costs, efficacy, and quality of life improvements before fuller deployment in clinical practice.[27]

PS non-pharmacologic interventions

Research on cognitive rehabilitation in children after brain injury is still quite limited, and we do not have strong evidence to guide many of the approaches used today. So far, a range of non-pharmacological methods has been explored, which mainly include exercise programs, psychological support, neuromodulation, computer-based cognitive training, brain-computer interfaces, VR activities, music therapy, and even acupuncture. While these interventions show promise, the overall data supporting them remain restricted.[30]

NMES avoids the brain and spinal cord to cause a reaction at the motor unit junction (the most common) or depolarises a neuron before it reaches the neuromuscular junction. According to research, NMES may cause the following changes in the brain: An increase in motor-evoked potentials, which measure how easily the brain produces movement, an increase in blood flow to brain regions linked to movement, an increase in the activity of genes that code for factors crucial to brain plasticity, and the formation of new neurons surrounding the lesion.[31]

In normal prepubertal children who engage in moderate-to-vigorous physical activity and exercises, particularly vigorous physical activity, they will have better cognitive functions than children with cerebral palsy.[32] Exercises were focused on strengthening muscles, reducing spasticity, enhancing transfer skills and postural adjustments, improving balance and posture control when standing and walking. To avoid contractures and maintain a complete active range of motion, a carbon fibre ankle-foot orthosis and a night-time brace for the right upper limb were used.[33] Psychological intervention is also essential to treat the emotional and social effects of stroke. Children who have suffered a stroke may experience anxiety, depression, or odd behaviour.[34] The most popular psychological intervention for kids with cognitive impairments following an ischaemic stroke is now strategy training.[35] Despite being rated National Health and Medical Research Council (NHMRC) grade D due to low evidence quality, it is the only treatment with direct medical support.[36] Support groups and psychological counselling can assist kids and their families in overcoming these obstacles and fostering emotional health.[37]

Music therapy has proven that it restores vital signs in children with neurological abnormalities both during and after treatment, as evidenced by lower heart rate, respiratory rate, and higher oxygen saturation.[38] According to brain imaging research, listening to music activates a broad bilateral network of frontal, temporal, parietal, and subcortical areas linked to attention, semantic and musical syntactic processing, memory, and motor function in addition to the auditory cortex.[5] VR is frequently utilised in children’s cognitive rehabilitation therapy to improve anxiety, happiness, and relaxation.[39] The combined effects of VR and computer game-based cognitive therapy create simulated environments where a person’s sense of agency, that is, the feeling of initiating and controlling their own actions, arises through coordinated sensorimotor interactions.[40]

Paediatric palliative care is defined by the WHO as measures taken to alleviate the suffering and enhance the quality of life for children with severe, chronic, progressive, incapacitating, advanced, or life-threatening illnesses, irrespective of the disease’s stage.[41] Compared to adult stroke rehabilitation services, PS rehabilitation services are less developed, and stroke incidence in children is low. Medical treatments, including physiotherapy and speech and language therapy, were also considered beneficial, according to Howdle et al.[42] PT, occupational therapy (OT), speech and language pathology (SLP), and physiatry (Physical Medicine and Rehabilitation Physician) should begin treating these patients.[43] Examples of motor interventions that could be useful for stroke rehabilitation in children include electromyography, triggered neuromuscular stimulation, functional electrical stimulation, bi-manual therapy, VR, and constraint-induced movement therapy (CIMT).[25] Despite this belief that therapeutic touch is a crucial component of clinical practice, there has been controversy about its application in paediatric PT, especially when it comes to children with cerebral palsy. Green light (do it), yellow light (moderate evidence, evaluate the results), and red light (lack of evidence, don’t do it) are the three categories of evidence for treatments, according to a recent systematic review. Any child-initiated method to problem-solving that did not involve a therapist’s touch, such as task-specific training and CIMT, was considered a ‘green light’ intervention.[44] Three main components make up CIMT: (1) Restricting the use of the less-impaired upper extremity (UE); (2) Practicing motor movements with the impaired UE on a daily basis under the guidance of a therapist for a prolonged period of time (2–3 weeks) and (3) Shaping more complex action patterns by rewarding successive approximations to the target action.[45] Repetitive TMS (rTMS) has been shown in some studies to enhance the grip strength of upper limb impairments following a childhood stroke. When rTMS and CIMT are applied together, the results are better than when CIMT is applied alone. The new aspect is that while tDCS by itself has not been effective and was not advised, its combination with CIMT or OT has had favourable results.[25] In contrast, OT seeks to enhance pertinent performing skills or create and instruct compensating procedures to regain lost performance skills to facilitate task performance.[46]

Several studies show that language difficulties, oral motor problems, difficulties in speech motor skills, and dysphagia often present as early manifestations of acute stroke among children. In neonates and children who have suffered from an acute arterial ischaemic stroke, 39–41% experience dysphagia. This is often associated with difficulties in motor speech and language. These problems can impact health outcomes and cause increased stress levels among caregivers if not addressed immediately.[47] Speech therapy is essential for children who have suffered from a stroke. Speech-language pathologists (SLPs) are the focal point of PS rehabilitation because they help assess oral motor strength. Provide therapy to address speech articulation, language, and swallowing. They also teach compensatory and rehabilitative strategies.[48] For the case of speech problems, which include dysarthria and aphasia, the following therapies are used: Articulation and phonation exercises to build the strength of the speaking muscles of the body. Language therapies, which include expressive and receptive language therapies. Data on aphasia therapies for children are limited, but language therapies can lead to neuroplastic adaptation.[49]

The major muscle groups used during speaking and swallowing are targeted by oral and pharyngeal motor exercises. These exercises are widely used as rehabilitative treatments. To improve lingual pressure, it is recommended that exercises to strengthen the tongue and improve pressure resistance be used. To improve laryngeal elevation, head lift, and shaker exercises may be used. To improve cough strength, exercise of the respiratory muscles may be used.[50] Despite the fact that much of this information is derived from adult stroke neurology, neuroplasticity and task specificity are applied to paediatric populations whenever possible. Since most of the research available today is based on adult post-stroke rehabilitation, it’s necessary for more paediatric-focused studies. These problems can impact health outcomes and cause increased stress levels among caregivers if not addressed [Table 1].

Table 1: Description of interventions used for PS.
Intervention Mechanism Outcomes Evidence level
CIMT Restricts the unimpaired limb while ‘shaping’ the impaired limb through repetitive, rewarded tasks. Improved motor function; development of complex action patterns. Green light (Strongest evidence for child-initiated therapy).
NMES/FES/NMS Depolarises motor units or neurons; increases cerebral blood flow and gene activity for brain plasticity. Increased motor-evoked potentials; formation of new neurons around the lesion. Moderate; often used to bypass brain/spinal cord injury.
rTMS Non-invasive electromagnetic induction to stimulate specific cortical areas. Enhanced grip strength and upper limb motor control. High (when combined); works better with CIMT than alone.
tDCS Uses low-level electrical currents to modulate neuronal excitability. Favourable results in task performance and motor recovery. Low (alone); Only advised when combined with OT or CIMT.
Nutritional: Protein and Omega-3 Protein aids muscle synthesis: Omega-3/Polyphenols provide anti-inflammatory and neuroprotective effects. Improved performance in daily tasks; brain repair and functional recovery. Promising, the trajectory of recovery is significantly impacted by early intake.
Speech and oral motor therapy Exercises for lingual pressure, laryngeal elevation (head lifts), and respiratory muscle training. Improved swallowing (dysphagia), articulation, and cough strength. Essential; addresses the 39–41% of cases with oral motor dysfunction.
VR/Computer training Uses sensorimotor interactions and simulated environments to trigger a ‘sense of agency’. Reduced anxiety; improved relaxation, happiness, and cognitive control. Moderate; frequently used to supplement traditional rehab.
Strategy training Teaching cognitive compensatory methods to navigate mental impairments. Improved independence in cognitive tasks. Grade D: Low evidence quality, yet the only treatment with direct medical support.
Music therapy Activates bilateral networks (frontal/parietal); influences the auditory cortex and motor areas. Restores vital signs (lower HR/RR); improves attention and memory. Moderate; shows physiological stabilisation during/after treatment.
PT/OT Task-specific training, balance control, and use of orthotics (AFO). Reduced spasticity; prevention of contractures; improved postural adjustments. Green light (for child-initiated, therapist-guided tasks).

AFO: Ankle-foot orthosis, CIMT: Constraint-induced movement therapy, NMES: Neuromuscular electrical stimulation, FES: Functional electrical stimulation, NMS: Neuromuscular stimulation, rTMS: Repetitive transcranial magnetic stimulation, tDCS: Transcranial direct current stimulation, OT: Occupational therapy, PT: Physical therapy, VR: Virtual reality, HR: Heart rate, RR: Respiratory rate; PS: Paediatric stroke

Neonates (<29 days of age) and children (29 days to <19 years) suffer from dysphagia and oral motor dysfunction due to arterial ischaemic stroke.[51] Dysphagia has a higher risk of malnutrition due to decreased dietary intake, increased nutritional requirements, and gastrointestinal issues. In turn, malnutrition can worsen functional impairment, developmental delay, and growth and increase morbidity.[52] For individuals with dysphagia, dietary modifications and nutritional support are the two main methods of addressing their nutritional requirements.[53] When combined with resistance training or structured exercise rehabilitation regimens, protein supplementation seemed to enhance functional outcomes. This suggests that consuming enough protein in addition to therapy may help patients perform better on daily tasks and build muscle. It has been shown that these advantages are more consistent than using non-protein supplements.[54] Nutrients such as polyphenols and omega-3 fatty acids can contribute to neuroprotective mechanisms due to their anti-inflammatory and antioxidative properties.[55] Beyond providing fundamental nutritional support, these fatty acids are essential because they influence the intricate processes of brain repair and functional recovery following a stroke. The trajectory of long-term recovery, particularly concerning cognitive and functional abilities, is significantly impacted by early post-stroke nutritional interventions.[56] Furthermore, micronutrients, including vitamin D and B-complex vitamins, are gaining recognition for their roles in neurological repair and cognitive function.[57,58] For managing gastrointestinal symptoms, soluble, viscous fibre (like psyllium) that has a high water-holding capacity and resistance to fermentation can help with diarrheal symptoms by promoting the formation of stools and slowing down transit time, and constipation symptoms by softening stools. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition recommends a 6-month assessment of children with neurological impairment utilising several approaches, such as height, weight, skinfold thickness, and mid upper arm circumference (MUAC). The nutritional treatment must strike a balance between preventing overnutrition and its negative long-term implications on cardiometabolic health and providing enough nutrition to sustain growth, development, and well-being.[59]

According to a few studies, post-stroke paediatric acquired brain injuries have been linked to fatigue. Fatigue factor is further associated with older age of patients, single-parent households, mental dysfunction, sleep disorders, and motor and physical disabilities.[60] Following a stroke, 20–78% of individuals experience disrupted sleep. Post-stroke sleep-associated disorders often get ignored due to a lack of awareness about them. The gold standard for identifying sleep disturbances is polysomnography (PSG), but because of its high cost and limited availability, PSG cannot be used on all stroke patients. Poor sleep profile is directly linked to a decline in neurological function and increased risk of further coronary heart disorders.[61] Various studies show how acute ischaemic stroke (AIS) often coexists with sleep-disordered breathing (SDB) and alterations in sleep architecture. SDB is a common complication of AIS. Rapid eye movement (REM) sleep architecture is the primary area of variation in acute ischaemic stroke patients with SDB. Various other types of sleep architecture modifications also occur, corresponding to varying degrees of sleep-disordered breathing. Keeping a close, long-term track of sleep in AIS patients can help clinicians design more personalised treatment plans and give patients a better chance of recovery. Due to technical constraints, current research on the possible link between stroke and sleep, particularly the ongoing changes in sleep states following stroke, remains very limited.[62]

Screening methods for stroke in the paediatric population

Stroke in children is uncommon compared with adults, but the impact is often much more complicated because the brain is still maturing at the time of injury. Consequently, the impact of a childhood stroke can extend beyond the child and influence the family’s daily routines, long-term decisions, and overall quality of life.[63] The delay in symptoms makes early detection especially vital. A key obstacle in identifying stroke in children is the absence of a unified screening protocol. Symptoms can vary widely with age. Older children usually show clearer neurological signs, especially sudden weakness of the face or limbs, and acute hemiparesis remains one of the most classic findings in arterial ischaemic stroke (AIS) in this age group. Younger children, however, are far less straightforward. Infants and toddlers frequently present with seizures, and many show only vague symptoms such as vomiting, fussiness, fever, or general instability, which can easily be mistaken for common infections or metabolic problems. Since focal deficits are often subtle in the youngest children, stroke is not always considered early, and this increases the risk of missed or delayed diagnosis. Because of this, tools built specifically for children and increased awareness among clinicians are essential.[20] When it comes to imaging, MRI is preferred in children whenever it is available quickly and does not require prolonged sedation. Unlike adults, where CT is often done first, children benefit from MRI because it avoids radiation, shows early ischaemic changes more clearly, and helps identify subtle vascular abnormalities that CT might miss. Since many stroke mimics in children also appear normal on CT, MRI provides more reliable early diagnostic information.[64]

CONCLUSION

Stroke is in the top 10 causes of death in children, and survivors have lifelong disabilities. It affects around 1 in 25,000 children annually, with 75% experiencing long-term neurologic morbidity. Its occurrence in children is highest in the neonatal period, having a significant impact on a child’s development, influencing the social skills, learning, and quality of life with motor impairments often manifesting as hemiparesis or hemiplegia. Congenital heart disease and transient cerebral arteriopathy are two common causes of PS. MRI, along with MRA and MRV, is preferred in children when it is required without prolonged sedation. It provides a much clearer view, especially when there is a requirement to check for venous thrombosis, look for areas of infarction, or assess the vascular details. An effective rehabilitation is critical for supporting the recovery and improving outcomes in affected children. A range of non-pharmacological methods mainly includes exercise programs, psychological support, neuromodulation, computer-based cognitive training, brain-computer interfaces, VR activities, music therapy, and even acupuncture. Exercises are focused on strengthening muscles, reducing spasticity, enhancing transfer skills and postural adjustments, improving balance and posture control when standing and walking. Robotic rehabilitation describes therapies that help retrain movement using robotic equipment (such as exoskeletons, robotic arms and legs, gait trainers, hand and arm robots, etc.). Although promising, more studies on PS are needed to evaluate treatment costs, efficacy, and quality of life outcomes before widespread clinical use.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient’s consent is not required as there are no patients in this study.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript, and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. , , , , , , et al. Australian Clinical Consensus Guideline: The diagnosis and acute management of childhood stroke. Int J Stroke. 2019;14:94-106.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , . Pediatric ischemic stroke: Clinical and paraclinical manifestations-algorithms for diagnosis and treatment. Algorithms. 2024;17:171.
    [CrossRef] [Google Scholar]
  3. , . Advances in the diagnosis and treatment of pediatric arterial ischemic stroke. Neurotherapeutics. 2023;20:633-54.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , . Virtual reality is a promising therapy tool for walking activities in pediatric neurorehabilitation: Evaluation of usability and user experience. JMIR Serious Games. 2022;10:e38509.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , , , , et al. Non-pharmacologic approaches to neurological stimulation in patients with severe brain injuries: A systematic review. Eur Rev Med Pharmacol Sci. 2022;26:6856-70.
    [Google Scholar]
  6. , , , , . Gaming technology for pediatric neurorehabilitation: A systematic review. Front Pediatr. 2022;10:775356.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , , , , et al. Evaluating transcranial magnetic stimulation (TMS) induced electric fields in pediatric stroke. Neuroimage Clin. 2021;29:102563.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Pediatric patient with ischemic stroke: Initial approach and early management. Children (Basel). 2021;8:649.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , , , , , et al. From brain injury to classroom: Cognitive and academic outcomes after pediatric stroke. A narrative review. Front Neurol. 2025;16:1680795.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , , , , et al. Pediatric stroke: Overview and recent updates. Aging Dis. 2021;12:1043-55.
    [CrossRef] [PubMed] [Google Scholar]
  11. , . Pediatric stroke: A review. Emerg Med Int. 2011;2011:734506.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , , , , et al. Intravenous tenecteplase thrombolysis and endovascular bridging intra-arterial tirofiban injection therapy in a pediatric case of acute ischemic stroke. BMC Neurol. 2025;25:348.
    [CrossRef] [PubMed] [Google Scholar]
  13. , . Stroke: Causes and clinical features. Medicine (Abingdon). 2020;48:561-6.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Establishing a pediatric acute stroke protocol: Experience of a new pediatric stroke program and predictors of acute stroke. Front Neurol. 2023;14:1194990.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , , et al. Global, regional, and national burden of stroke on children and adolescents aged under 20 years from 1990 to 2021, with projections of disability-adjusted life year to 2050: A comprehensive demographic analysis for the global burden of disease study 2021. Eur J Neurol. 2025;32:e70180.
    [CrossRef] [Google Scholar]
  16. , . A study of risk factors and clinical outcome of stroke in children. Int J Contemp Pediatr. 2019;6:1439.
    [CrossRef] [Google Scholar]
  17. , , , . Pediatric acute ischemic stroke by age-group: A systematic review and meta-analysis of published studies and hospitalization records. Neuroepidemiology. 2021;55:331-41.
    [CrossRef] [PubMed] [Google Scholar]
  18. , . Pediatric acute ischemic cerebral vascular accidents: A case report. Pediatr Emerg Care. 2017;33:188-9.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , , , , et al. Current state of the global pediatric stroke care-results from the global alliance for pediatric stroke epidemiology and resources survey. Pediatr Neurol. 2026;174:101-9.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , . Pediatric stroke: A review of common etiologies and management strategies. Biomedicines. 2022;11:2.
    [CrossRef] [PubMed] [Google Scholar]
  21. , . Pediatric stroke: Unique implications of the immature brain on injury and recovery. Pediatr Neurol. 2020;102:3-9.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , . Mineralizing angiopathy with basal ganglia stroke after minor head trauma; a clinical profile and follow up study of a large series of paediatric patients from North India. Eur J Paediatr Neurol. 2021;33:61-7.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , , , et al. Long-term neurologic outcomes in pediatric arterial ischemic stroke: The impact of age and lesion location. Stroke. 2024;55:2622-31.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , , , , et al. Management of stroke in neonates and children: A scientific statement from the American Heart Association/American Stroke Association. Stroke. 2019;50:e51-96.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , , , et al. A review of current perspectives on motoric insufficiency rehabilitation following pediatric stroke. Healthcare (Basel). 2024;12:149.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , . Upper limb robotic neurorehabilitation after pediatric stroke. Srp Arh Celok Lek. 2020;148:15.
    [CrossRef] [Google Scholar]
  27. , , , , . Robotic exoskeleton gait training in stroke: An electromyography-based evaluation. Front Neurorobot. 2021;15:733738.
    [CrossRef] [PubMed] [Google Scholar]
  28. , . Pediatric robotic rehabilitation: Current knowledge and future trends in treating children with sensorimotor impairments. NeuroRehabilitation. 2017;41:69-76.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , , . Neuromotor rehabilitation interventions after pediatric stroke: A focused review. Semin Pediatr Neurol. 2022;44:100994.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , , , . The influential factors and non-pharmacological interventions of cognitive impairment in children with ischemic stroke. Front Neurol. 2022;13:1072388.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , , . Neuromuscular electrical stimulation for children with stroke. Arch Phys Med Rehabil. 2023;105:191-5.
    [CrossRef] [PubMed] [Google Scholar]
  32. , , , , , , et al. A six week therapeutic ballet intervention improved gait and inhibitory control in children with cerebral palsy-a pilot study. Front Public Health. 2019;7:137.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , , , , et al. Multidisciplinary rehabilitation of a post-stroke pediatric patient considering the ICF perspective. J Pediatr Rehabil Med. 2020;13:255-62.
    [CrossRef] [PubMed] [Google Scholar]
  34. , , . The impact of pediatric basal ganglia stroke on mental health in children: Report of 2 cases. Child Neurol Open. 2020;7:2329048X20979248.
    [CrossRef] [PubMed] [Google Scholar]
  35. , , . Improving cognitive outcomes for pediatric stroke. Curr Opin Neurol. 2017;30:127-32.
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , , , , et al. Australian clinical consensus guideline for the subacute rehabilitation of childhood stroke. Int J Stroke. 2021;16:311-20.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , , . Characteristics and functional outcomes of pediatric stroke survivors at a rehabilitation unit in Saudi Arabia. J Clin Neurosci. 2020;81:403-8.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , , , , et al. Music therapy supports children with neurological diseases during physical therapy interventions. Int J Environ Res Public Health. 2022;19:1492.
    [CrossRef] [PubMed] [Google Scholar]
  39. , , , , , , et al. Real-time reorientation and cognitive load adjustment allow for broad application of virtual reality in a pediatric hospital. J Clin Transl Res. 2021;7:750-3.
    [Google Scholar]
  40. . Combined effects of virtual reality and computer game-based cognitive therapy on the development of visual-motor integration in children with intellectual disabilities: A pilot study. Occup Ther Int. 2021;2021:6696779.
    [CrossRef] [PubMed] [Google Scholar]
  41. , , , , , . The role of physiotherapy in pediatric palliative care: A systematic review. Children (Basel). 2021;8:1043.
    [CrossRef] [PubMed] [Google Scholar]
  42. , , , . Factors influencing recovery from pediatric stroke based on discussions from a UK-based online stroke community: Qualitative thematic study. J Med Internet Res. 2024;26:e49409.
    [CrossRef] [PubMed] [Google Scholar]
  43. , . Pediatric stroke: From emergent evaluation to rehabilitation. Curr Probl Pediatr Adolesc Health Care. 2025;55:101878.
    [CrossRef] [PubMed] [Google Scholar]
  44. , , . The significance of touch in pediatric physiotherapy. Front Rehabil Sci. 2022;3:893551.
    [CrossRef] [PubMed] [Google Scholar]
  45. , . Constraint-induced movement therapy (CIMT): Pediatric applications. Dev Disabil Res Rev. 2009;15:102-11.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , , , , . Occupational therapy for stroke patients: a systematic review. Stroke. 2003;34:676-87.
    [CrossRef] [PubMed] [Google Scholar]
  47. , , , , , , et al. Swallowing, oral motor, motor speech, and language impairments following acute pediatric ischemic stroke. Stroke. 2021;52:1309-18.
    [CrossRef] [PubMed] [Google Scholar]
  48. , . Clinical outcomes associated with speech, language and swallowing difficulties post-stroke. S Afr J Commun Disord. 2023;70:e1-15.
    [CrossRef] [PubMed] [Google Scholar]
  49. , , , . Treatment for pediatric aphasia: A critical review. J Stud Res. 2020;6:955.
    [CrossRef] [Google Scholar]
  50. , , , , , . Tongue pressure resistance training for post-stroke dysphagia: A case study. Folia Phoniatr Logop. 2024;76:577-87.
    [CrossRef] [PubMed] [Google Scholar]
  51. , . Hard to swallow: Dysphagia and feeding after ischemic stroke in children and neonates. Stroke. 2021;52:1319-21.
    [CrossRef] [PubMed] [Google Scholar]
  52. , , , , , . Prevalence of drooling, swallowing, and feeding problems in cerebral palsy across the lifespan: A systematic review and meta-analyses. Dev Med Child Neurol. 2019;61:1249-58.
    [CrossRef] [PubMed] [Google Scholar]
  53. , , , , , . Nutritional issues in children with dysphagia. Nutrients. 2024;16:1590.
    [CrossRef] [PubMed] [Google Scholar]
  54. , , , , , , et al. Oral nutritional interventions for stroke recovery: A systematic review. Nutr Rev. 2026;84:615-32.
    [CrossRef] [PubMed] [Google Scholar]
  55. , , , , , . High-fat diet and aging interact to produce neuroinflammation and impair hippocampal-and amygdalar-dependent memory. Neurobiol Aging. 2017;58:88-101.
    [CrossRef] [PubMed] [Google Scholar]
  56. , , , , , , et al. Influence of nutritional interventions on functional outcomes in stroke rehabilitation: A systematic review. Cureus. 2024;16:e53711.
    [CrossRef] [Google Scholar]
  57. , , , , , . Vitamin D epimers are associated with circulating haemoglobin levels independently of C-reactive protein. Sci Rep. 2021;11:20747.
    [CrossRef] [PubMed] [Google Scholar]
  58. , , , , , , et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS One. 2010;5:e12244.
    [CrossRef] [PubMed] [Google Scholar]
  59. , , , , , . The evolution of nutrition management in children with severe neurological impairment with a focus on cerebral palsy. J Hum Nutr Diet. 2025;38:e13277.
    [CrossRef] [PubMed] [Google Scholar]
  60. , , , , , , et al. Fatigue following pediatric arterial ischemic stroke: Prevalence and associated factors. Stroke. 2021;52:3286-95.
    [CrossRef] [PubMed] [Google Scholar]
  61. , , , , , , et al. Relationship between sleep disorders and the prognosis of neurological function after stroke. Front Neurol. 2022;13:1036980.
    [CrossRef] [PubMed] [Google Scholar]
  62. , , , , , , et al. Sleep architecture characteristics in patients with acute ischemic stroke. Sci Rep. 2025;15:16996.
    [CrossRef] [PubMed] [Google Scholar]
  63. . RCPCH clinical guideline, stroke in childhood: An evidence-based guideline for diagnosis, management, and rehabilitation. Clin Radiol. 2017;72:S25.
    [CrossRef] [Google Scholar]
  64. , , , . Neuroimaging advances in pediatric stroke. Stroke. 2019;50:240-8.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections